Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS
致病性帕金森病突变在中枢神经系统中α-突触核蛋白播种和传播中的作用
基本信息
- 批准号:9764564
- 负责人:
- 金额:$ 42.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBasal GangliaBehavioralBiological ProcessBrainBrain StemCa(2+)-Calmodulin Dependent Protein KinaseCatecholaminesCognitiveCommunitiesCorpus striatum structureDNA Sequence AlterationDevelopmentDiseaseEnteralEnvironmentEtiologyFilamentFunctional disorderGene ActivationGenesGeneticHippocampus (Brain)HumanInfectionInflammationInflammatory ResponseInfluenzaInfluenza A Virus, H1N1 SubtypeInjectionsLRRK2 geneLeadLeucine-Rich RepeatLewy BodiesMotorMotor outputMusMutationNervous system structureNeuraxisNeuritesParkinson DiseaseParkinsonian DisordersPathogenesisPathogenicityPathologicPathologic ProcessesPathologyPathway interactionsPatternPhosphorylationPhosphotransferasesPlayPost-Translational Protein ProcessingProtein KinaseProteinsRespiratory Tract InfectionsRiskRisk FactorsRoleSalineSeedsSusceptibility GeneSymptomsSystemTestingVirus Diseasesalpha synucleindopaminergic neurongene environment interactionglucosylceramidaseimmune activationinfluenzavirusinternal controlmisfolded proteinmonoaminemutantneuroinflammationneuron lossnovelolfactory bulbprotein aggregaterisk variantsynucleinsynucleinopathy
项目摘要
Abstract
The etiology of Parkinson’s disease is multivariate, ranging from identified genetic mutations to
strict environmental causation. So far, more than 18 genes have been identified that result in parkinsonism.
The two most common genetic mutations that lead to parkinsonism are: 1) mutations in the GBA gene that
encodes the glucocerebrosidase protein, and 2) mutations in the LRRK2 gene that Leucine Rich Repeat
Kinase II protein. In addition to their known “genetic i.e familial” relationship to disease causation, both
the GBA and LRRK2 genes are also considered to be “risk factors” for development of PD, in that not
everyone with these mutations develops Parkinson’s disease and they may only manifest after a second
“hit”. No matter the initiating cause of PD, almost all cases of Parkinson’s disease share common aspects
of pathology, including: 1) the presence of aggregated alpha-synuclein, 2) loss of SNpc DA neurons and 3)
an increase in neuroinflammation. Additionally, one also sees cognitive and motor output changes. In this
application, the we will examine different pathological mechanisms known to initiate Parkinson’s disease,
including protein kinase activation, protein management or inflammation will alter/affect the aggregation
and spread of α-syn throughout the nervous system. Specifically, we will examine the effect on PD
pathophysiology including SNpc DA neuron loss, loss of basal ganglia catecholamines, induction of
neuroinflammation and spread of misfolded alpha-synuclein. We will also examine if cognitive and motor
behavioral changes occur in these 3 conditions after PFF seeding. These parkinsonian pathologies will be
examined following injection of preformed filaments of alpha-synuclein (PFFs) into three different regions
of the CNS, including two known to be involved in PD (olfactory bulb and striatum) and one that is not
(internal control, hippocampus). In Specific Aim 1, we will examine if PFFs injected into different regions
of the CNS of mice carrying a G2019S mutation in the LRRK2 gene alter the seeding and spread of α-Syn
as well as alter other known pathologies in PD as described above. In Specific Aim 2, we will examine if
preformed fibrils of alpha-synuclein (PFFs) injected into different regions of the CNS of mice carrying a
L444P GBA mutation alters the seeding and spread of α-Syn as well as alter other known pathologies in
PD as described above. In Specific Aim 3 we will test the hypothesis that a prior neuroinflammatory insult
(infection with the H1N1 influenza virus) to the brain will increase the seeding and spread of PFFs in mice
carrying PD susceptibility genes as well as alter other known pathologies in PD as described above. These
three aims will allow us to determine if any one or more of these pathological mechanisms (kinase activation
(genetic), protein mishandling (gene x environment” or viral infection (environment) directly influence the
spread of misfolded alpha-synuclein and other common parkinsonian pathologies.
抽象的
帕金森氏病的病因是多元的,从确定的基因突变到
严格的环境原因。到目前为止,已经确定了18种导致帕金森氏症的基因。
导致帕金森氏症的两个最常见的遗传突变是:1)GBA基因中的突变,
编码葡萄糖脑苷酶蛋白,并在LRRK2基因中进行2)突变,该突变富含亮氨酸重复
激酶II蛋白。除了它们已知的“遗传性遗传性”与疾病原因的关系
GBA和LRRK2基因也被认为是PD发展的“风险因素”,因为
每个患有这些突变的人都会发展出帕金森氏病,只有一秒钟才能表现出来
“打”。无论是PD的发射原因,几乎所有帕金森氏病的病例都有共同的方面
病理学,包括:1)存在聚集的α-核蛋白,2)SNPC DA神经元的丧失和3)
神经炎症的增加。此外,人们还看到认知和电动机输出变化。在这个
应用,我们将检查已知启动帕金森氏病的不同病理机制,
包括蛋白质激酶激活,蛋白质管理或注射将改变/影响聚集
α-Syn在整个神经系统中的传播。具体来说,我们将研究对PD的影响
病理生理学包括SNPC DA神经元丧失,基底神经节儿茶酚胺的丧失,诱导
神经炎症和错误折叠的α-突触核蛋白的传播。我们还将检查认知和运动是否
PFF播种后,在这3个条件下发生行为变化。这些帕金森病将是
在注射α-突触核蛋白(PFF)预先形成的细丝后检查成三个不同的区域
中枢神经系统的中枢神经系统,包括已知参与PD的两个(嗅球和纹状体),一个不是
(内部控制,海马)。在特定目标1中,我们将检查是否注入了不同区域的PFF
在LRRK2基因中携带G2019S突变的小鼠中枢神经系统的中枢神经系统改变了α-Syn的播种和扩散
以及如上所述改变PD中的其他已知病理。在特定目标2中,我们将检查是否
注入载有A的小鼠中枢神经系统区域的α-核蛋白(PFF)的原纤维
L444p GBA突变改变了α-Syn的播种和扩散,并改变了其他已知病理学
如上所述的PD。在特定目标3中,我们将检验以下假设:先前的神经炎性损伤
(感染H1N1影响力病毒)大脑会增加小鼠PFF的播种和扩散
如上所述,携带PD敏感性基因以及更改PD中的其他已知病理。这些
三个目标将使我们能够确定是否有任何一种或多种病理机制(激酶激活
(遗传),蛋白质不当(基因X环境”或病毒感染(环境)直接影响
alpha-甲核蛋白和其他常见的帕金森氏病的传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD J SMEYNE其他文献
RICHARD J SMEYNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD J SMEYNE', 18)}}的其他基金
Synergistic Interactions of SARs-CoV2 and environmental toxicants in Experimental Parkinsonism
SARs-CoV2 与环境毒物在实验性帕金森病中的协同相互作用
- 批准号:
10316307 - 财政年份:2021
- 资助金额:
$ 42.18万 - 项目类别:
Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS
致病性帕金森病突变在中枢神经系统中α-突触核蛋白播种和传播中的作用
- 批准号:
10599135 - 财政年份:2019
- 资助金额:
$ 42.18万 - 项目类别:
Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS
致病性帕金森病突变在中枢神经系统中α-突触核蛋白播种和传播中的作用
- 批准号:
10382329 - 财政年份:2019
- 资助金额:
$ 42.18万 - 项目类别:
H5N1 Influenza Virus as a Novel Etiological Agent in Parkinsons Disease
H5N1 流感病毒作为帕金森病的新病原体
- 批准号:
7825434 - 财政年份:2009
- 资助金额:
$ 42.18万 - 项目类别:
相似国自然基金
干细胞移植重建缺氧缺血损伤脑基底神经节环路
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
干细胞移植重建缺氧缺血损伤脑基底神经节环路
- 批准号:32270849
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
光遗传在基底神经节-丘脑-皮层神经回路脑疾病中的动力学建模调控
- 批准号:
- 批准年份:2020
- 资助金额:62 万元
- 项目类别:
rTMS通过前额叶-基底神经节环路调控射精行为的信息处理机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:
基底神经节兴奋—抑制通路对运动疲劳的调控作用及机制研究
- 批准号:31971095
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
- 批准号:
10751224 - 财政年份:2024
- 资助金额:
$ 42.18万 - 项目类别:
Modeling and Mapping Human Action Regulation Networks
人类行为调节网络的建模和映射
- 批准号:
10712708 - 财政年份:2023
- 资助金额:
$ 42.18万 - 项目类别:
EFFECTS OF DISEASE AND PALLIDAL DEEP BRAIN STIMULATION ON ANKLE MUSCLE CONTROL IN PARKINSON'S DISEASE
疾病和苍白球深部脑刺激对帕金森病患者踝关节肌肉控制的影响
- 批准号:
10749673 - 财政年份:2023
- 资助金额:
$ 42.18万 - 项目类别:
Significance of Protein Synthesis by the Integrated Stress Response in Neuromodulatory Neurons for Adaptive Behavior and Synaptic Plasticity
神经调节神经元综合应激反应蛋白质合成对适应性行为和突触可塑性的意义
- 批准号:
10718345 - 财政年份:2023
- 资助金额:
$ 42.18万 - 项目类别:
Peripheral Inflammation and Stress Drive Ventral Striatal Maladaptations
周围炎症和压力导致腹侧纹状体适应不良
- 批准号:
10828485 - 财政年份:2023
- 资助金额:
$ 42.18万 - 项目类别: